Top 10 Companies in the Medicinal White Oil Market (2026): Market Leaders Powering Global Pharmaceutical Innovation

In Business Insights
July 21, 2026


MARKET INTELLIGENCE OVERVIEW

Medicinal White Oil Market

Medicinal white oil is a highly refined, pharmacopeial‑grade mineral oil used as an inert carrier in topical, oral, and parenteral pharmaceutical formulations. Its chemical stability, non‑reactivity, and excellent skin‑penetration characteristics make it ideal for delivering active ingredients, while meeting stringent safety standards for human use. Growing demand for clean‑label cosmetics, increasing prevalence of dermatological treatments, and expanding generic drug production are driving market expansion worldwide.

📊
Current Market Size
520 USD Mn

2025 Value

📈
CAGR
4.3%

2026–2034

🎯
Forecast Market Size
860 USD Mn

By 2034

Strategic Market Outlook
Long‑Term Industry Perspective
The Medicinal White Oil market is expected to benefit from rising demand for high‑purity carrier oils in pharmaceutical and personal‑care products, as well as expanding regulatory acceptance of mineral‑oil‑based excipients in emerging economies.

🌐
Leading Region
North America

🌍
Emerging Region
Asia‑Pacific

Market Insight Overview

The Medicinal White Oil market was valued at USD 520 million in 2025 and is projected to reach USD 860 million by 2034, reflecting a CAGR of 4.3% between 2026 and 2034. This trajectory is driven by a surge in demand for high‑purity carrier oils across pharmaceutical, dermatological, and cosmetic sectors.

Medicinal White Oil Market – View in Detailed Research Report

What is Medicinal White Oil?

Medicinal white oil is a highly refined, pharmacopeial‑grade mineral oil that serves as an inert carrier in topical, oral, and parenteral pharmaceutical formulations. Its chemical stability, non‑reactivity, and excellent skin‑penetration properties enable it to deliver active ingredients safely and effectively.

Top 10 Companies in the Medicinal White Oil Market (2026)

1. Sasol

Headquarters: South Africa
Key Offering: Pharmaceutical‑grade white oil with low impurity profile

Sasol’s integrated refining complex delivers consistently low‑impurity white mineral oil that meets stringent pharmacopeial standards. Long‑standing supply contracts with major generic manufacturers provide a stable revenue base and enable continued investment in advanced distillation technology.

Sustainability & Growth Initiatives: Investment in low‑carbon refining processes and partnership with global generic drug producers to secure supply continuity.

  • Advanced distillation technology for higher purity.
  • Strategic agreements with generic manufacturers.
  • Focus on process efficiency and waste minimisation.

2. BASF SE

Headquarters: Germany
Key Offering: Bulk and specialty white oil blends for pharmaceutical and cosmetic use

BASF leverages its expansive distribution network to supply both bulk and high‑purity grades, supporting a wide range of applications from injectable formulations to cosmetic bases.

Sustainability & Growth Initiatives: R&D focused on oxidative stability and reduced aromatic content to enhance formulation safety.

  • Investments in green chemistry for cleaner refining.
  • Partnerships with cosmetic brands for high‑purity blends.
  • Continuous improvement of product performance.

3. Dow Chemical

Headquarters: United States
Key Offering: Pharmaceutical‑grade white oil and specialty blends

Dow provides a broad portfolio of white oil grades, combining robust supply chains with R&D aimed at improving purity and reducing residual aromatics.

Sustainability & Growth Initiatives: Development of advanced distillation units to lower energy consumption.

  • Energy‑efficient refining processes.
  • Collaboration with generic drug manufacturers.
  • Enhanced product traceability.

4. Jilin Hengya

Headquarters: China
Key Offering: Cost‑effective white oil grades for domestic pharmaceutical exporters

Jilin Hengya capitalises on lower production costs and rapidly scales capacity to meet the growing demand of China’s domestic pharmaceutical market.

Sustainability & Growth Initiatives: Expansion of refining capacity and focus on product consistency.

  • Investment in process automation.
  • Quality control enhancements.
  • Domestic market penetration.

5. Jiangsu Yangtze

Headquarters: China
Key Offering: High‑purity white oil for pharmaceutical use

Jiangsu Yangtze’s focus on scalable production supports the domestic demand for high‑purity excipients.

Sustainability & Growth Initiatives: Adoption of precision solvent extraction to ensure consistent purity.

  • Process optimisation for purity.
  • Strategic supply agreements.
  • Technology upgrades.

6. Croda International

Headquarters: United Kingdom
Key Offering: Specialty lipid integration for transdermal delivery

Croda incorporates white oil into its broader portfolio of specialty lipids, targeting formulation‑centric applications such as emollients and transdermal carriers.

Sustainability & Growth Initiatives: Focus on innovative lipid blends to enhance therapeutic efficacy.

  • Research into novel lipid formulations.
  • Collaborations with pharma R&D teams.
  • Commitment to high‑purity standards.

7. Sunseeker Chemicals

Sunseeker offers tailored viscosity and purity specifications, catering to emerging therapeutic modalities in the Indian market.

Sustainability & Growth Initiatives: Agile production to meet client‑specific requirements.

  • Flexible manufacturing lines.
  • Client‑centric quality assurance.
  • Rapid response to market changes.

8. Kiyo Chemical

Kiyo focuses on delivering high‑purity grades that meet stringent regulatory requirements for advanced pharmaceutical products.

Sustainability & Growth Initiatives: Precision refining to maintain consistent quality.

  • Investment in advanced refining equipment.
  • Partnerships with specialty drug developers.
  • Quality‑first manufacturing philosophy.

9. Evonik Industries

Evonik delivers premium grades with low residual aromatics, supporting advanced drug delivery systems.

Sustainability & Growth Initiatives: R&D into oxidative stability and low‑carbon processes.

  • Advanced oxidation research.
  • Green refining initiatives.
  • Strategic alliances with pharma innovators.

10. Clariant

Clariant’s portfolio supports both bulk and specialty grades, emphasizing purity and consistency.

Sustainability & Growth Initiatives: Focus on clean‑process technology and reduced waste.

  • Investment in low‑energy refining.
  • Partnerships with cosmetic and pharma brands.
  • Commitment to sustainability reporting.



Download FREE Sample Report



Get Full Report

Strategic Outlook

The market is poised for steady expansion as demand for high‑purity carrier oils continues to rise across pharmaceutical, dermatological, and cosmetic sectors. Companies that invest in advanced refining technologies and secure reliable supply chains will strengthen their competitive position and unlock new revenue streams.

Future Trends

Key trends shaping the next decade include the development of ultra‑high purity grades, increased regulatory approvals for mineral‑oil‑based excipients, and a growing emphasis on sustainable sourcing of base oils. Digital supply‑chain platforms are enhancing traceability and reducing risk, while sustainability credentials are becoming a critical factor in brand differentiation.